CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Oct. 24, 2015	Oct. 25, 2014
Cash flows from operating activities
Net income	$ 35,782	$ 33,019
Adjustments to reconcile net income to cash provided by (used for) operating activities
Restructuring	352	(332)
Deferred income tax expense (benefit)	138	(1,799)
Provision for doubtful accounts	(426)	(1,113)
Depreciation and amortization	12,679	10,996
Equity-based compensation expense	5,123	5,047
Pension plan contributions	(7,000)
Change in receivables	4,980	(2,135)
Change in inventories	(21,501)	(11,006)
Change in other assets	(5,656)	6,253
Change in payables	(628)	(785)
Change in other liabilities	(2,120)	(6,377)
Net cash provided by operating activities	21,723	31,768
Cash flows from investing activities
Proceeds from disposal of assets	2,491	6,534
Capital expenditures	(13,949)	(40,580)
Purchases of investments	(11,693)	(24,224)
Proceeds from sales of investments	19,409	17,827
Acquisitions, net of cash acquired	(19,232)
Change in restricted cash	660	7,287
Net cash used for investing activities	(22,314)	(33,156)
Cash flows from financing activities
Net proceeds from credit facility	4,000
Payments on debt	(283)	(7,358)
Stock issued for stock and employee benefit plans	253	161
Excess tax benefit on stock option exercises	392	252
Purchases of common stock	(18,461)	(19,654)
Dividends paid	(8,112)	(6,274)
Net cash used for financing activities	(22,211)	(32,873)
Effect of exchange rate changes on cash and equivalents	(934)	(75)
Change in cash and equivalents	(23,736)	(34,336)
Cash and equivalents at beginning of period	98,302	149,661
Cash and equivalents at end of period	$ 74,566	115,325
Supplemental disclosure of non-cash investing activities
Capital expenditures included in payables		$ 5,339